ALMRNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Alamar Biosciences, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$26.30+1.02 (+4.03%)
Close on Oct 19, 2026
- Market cap
- $1.54B
- P/E (TTM)
- –
- Dividend yield
- –
Alamar Biosciences statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Laboratory Analytical Instruments companies for comparison
Valuation
| Measure | Alamar Biosciences | Industry median |
|---|---|---|
| Market Cap | $1.83B | $230.55M |
| Enterprise Value | $1.57B | $202.97M |
| PB Ratio | 5.83 | 3.04 |
| P/TBV Ratio | 5.83 | 4.43 |
Balance sheet
| Measure | Alamar Biosciences | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $250.05M | $36.66M |
| Net Cash (Debt) | $250.05M | $3.92M |
| Net Cash Per Share | $3.60 | $0.28 |
| Equity (Book Value) | $312.86M | $55.33M |
| Book Value Per Share | $4.51 | $2.87 |
| Tangible Book Value | $312.86M | $10.79M |
| Working Capital | $303.42M | $56.72M |
Financial position
| Measure | Alamar Biosciences | Industry median |
|---|---|---|
| Current Ratio | 11.85 | 2.48 |
| Quick Ratio | 9.67 | 1.53 |
Shares
| Measure | Alamar Biosciences | Industry median |
|---|---|---|
| Shares Outstanding | 69,392,800 | 44,302,700 |
| Float | 43,833,500 | 37,462,700 |
| Shares Held by Insiders | 36.8% | 10.5% |
| Shares Held by Institutions | 35.1% | 63.5% |
Scores
| Measure | Alamar Biosciences | Industry median |
|---|---|---|
| Altman Z-Score | 14.22 | 1.95 |
Calculated by StockData from Alamar Biosciences's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.